Amoéba has received marketing authorization in France for its biofungicide AXPERA

Amoéba has received marketing authorization in France for its biofungicide AXPERA

Chassieu, July 01, 2026 (GLOBE NEWSWIRE) -- Amoéba (FR0011051598 - ALMIB), industrial greentech specialized in the development of natural microbiological solutions, announces that it has obtained marketing authorization for its biofungicide AXPERA in France. This first authorisation, granted by ANSES…

Amoéba receives marketing authorization in France for AXPERA

Amoéba has obtained marketing authorization for its biofungicide AXPERA in France. The approval, granted by ANSES following an evaluation in which France acted as rapporteur Member State for the European Union, opens the door for other concerned Member States to proceed with and finalize their own…